Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
Clinical trial NCT04742634 · RECRUITING
Trial details
- NCT number
- NCT04742634
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-12
- Primary completion
- 2033-11-30
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.